How Krystal Biotech, Inc. stacks up

KRYS · against 172 other Healthcare companies of similar size

Overall

78/ 100

Near the top of its peers.

Ranked #4 of 173 · scores higher than 97% of peers

Bars: peers in each 10-point band of the overall score

25 peers with an overall score of 70–79, including KRYS · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#98 of 179Score 50 / 100 · beats 44%Growth#42 of 164Score 80 / 100 · beats 72%Profitability#12 of 173Score 94 / 100 · beats 91%Risk#17 of 175Lower relative risk · safety 87 · beats 91%

Ranking by overall score

Top 5 and the companies ranked around KRYS

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	RemeGen Co., Ltd.9995.HK · Hong Kong	37.3B HKD (≈$4.8B)	90	99	98	84	0 / 2
2	Lupin LimitedLUPIN.NS · India	921.9B INR (≈$11.1B)	82	84	80	94	0 / 2
3	Asahi Intecc Co., Ltd.7747.T · Japan	936.1B JPY (≈$6.4B)	80	65	86	94	0 / 2
4	Globus Medical, Inc.GMED · US-listed	10.7B USD	78	77	85	84	0 / 2
4	Krystal Biotech, Inc.KRYS · US-listed	9.0B USD	78	50	80	94	0 / 2
4	Ligand Pharmaceuticals IncorporatedLGND · US-listed	6.3B USD	78	50	90	86	0 / 2
4	Orion OyjORNAV.HE · Europe	13.9B EUR (≈$15.3B)	78	68	75	99	0 / 2
8	Glenmark Pharmaceuticals LimitedGLENMARK.NS · India	679.6B INR (≈$8.2B)	77	65	75	91	0 / 2
8	Pro Medicus LimitedPME.AX · Australia & NZ	20.0B AUD (≈$13.2B)	77	38	87	99	0 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…